Search results
Chipotle (CMG) Stock Surges 35% YTD: What's Next for Investors?
Zacks via Yahoo Singapore Finance· 2 hours agoAdditionally, the company has been benefiting from increased transaction growth. Chipotle’s stock...
SAP Stock Surges 31.4% Year to Date: Will the Momentum Last?
Zacks via Yahoo Singapore Finance· 2 hours agoSAP's performance is driven by continued strength in its cloud business. However, global...
Microsoft (MSFT) Announces Story Details of Upcoming Game CLeM
Zacks via Yahoo Singapore Finance· 2 hours agoHowever, the stock outperformed SONY, which lost 9.5%, followed by EA and NTDOY’s rise of 1.4% and...
Dare to bare: 24 of the world’s best nude beaches
CNN via Yahoo Style Singapore· 2 hours agoFrom big-city bays to secluded shores, there are hundreds of beaches where you can legally frolic while naked. If you’re so inclined, strip off that...
GSK Buys Flu, COVID mRNA Jab Rights From Partner CureVac
Zacks via Yahoo Singapore Finance· 2 hours agoGSK revamps its existing collaboration deal with partner CureVac, converting it from a collaboration...
LiveOne (LVO) & Seekr to Unveil AI-Driven Music Search Platform
Zacks via Yahoo Singapore Finance· 2 hours agoLiveOne (LVO) teams up with Seekr to launch an AI-infused music search platform for creators to...
Carlyle (CG) Thrives on Organic Growth Amid High Costs
Zacks via Yahoo Singapore Finance· 3 hours agoCarlyle (CG) is set to benefit from its efforts to grow organically. However, a rise in expenses due...
Euronext Amsterdam's High Insider Ownership Growth Companies For July 2024
Simply Wall St. via Yahoo Singapore Finance· 3 hours agoAmidst a backdrop of fluctuating European markets and rising bond yields, the Netherlands stock...
Here's Why You Should Hold Brighthouse Financial (BHF) Now
Zacks via Yahoo Singapore Finance· 3 hours agoBrighthouse Financial (BHF) gains from higher annuity and life insurance sales, conservative...
Roche's (RHHBY) Combo Therapy Misses Lung Cancer Study Goals
Zacks via Yahoo Singapore Finance· 3 hours agoRoche (RHHBY) announces that its mid to late-stage lung cancer study evaluating the tiragolumab...